Observational analysis found that blood contamination reduces microhardness in glass-ionomer cement, suggesting it impacts material integrity.
The aim of this study was to evaluate the effect of human blood contamination, before and after hardening of the materials, on microhardness of high-viscosity Fuji IX GP Extra (Fuji IX) and resin-modified Fuji II LC (Fuji II) glass-ionomer cement (GIC) and glass-hybrid material EQUIA Forte HT (EQUIA), with and without protective coating EQUIA Forte Coat (Coat), before and after thermocycling. Four groups (n = 40): 1. Fuji IX; 2. Fuji II; 3. EQUIA and 4. EQUIA + Coat were further subdivided into 3 subgroups: (1) Control; (2) blood contamination before hardening; (3) blood contamination after hardening, resulting in a total of 12 groups of 10 samples each. Samples were prepared using teflon molds (5 mm × 2 mm). Microhardness was measured using a Vickers microhardness tester before and after thermocycling (10,000 cycles), and data were statistically analyzed (Kolmogorov–Smirnov test, ANOVA, Scheffe’s test). In the control groups, the highest microhardness was measured for EQUIA+Coat before thermocycling (70.71 ± 8.79) and after thermocycling (68.6 ± 7.65). Within the groups exposed to blood after hardening, the highest microhardness was recorded in the thermocycled EQUIA+Coat group (73.07 ± 8.85). Blood contamination before hardening negatively affected the microhardness of Fuji II, Fuji IX, and EQUIA+Coat. Exposure to blood after hardening increased the microhardness of Fuji IX and EQUIA, thermocycled Fuji IX and thermocycled EQUIA + Coat samples.
No takes yet. Share an insight, caveat, or question.
Franić et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: